

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.99746561 |
| 2 | neutrophil activation (GO:0042119) | 5.81589566 |
| 3 | granulocyte activation (GO:0036230) | 5.54917495 |
| 4 | regulation of activation of Janus kinase activity (GO:0010533) | 5.49000377 |
| 5 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.43540714 |
| 6 | detection of other organism (GO:0098543) | 5.42459975 |
| 7 | NIK/NF-kappaB signaling (GO:0038061) | 5.27733953 |
| 8 | detection of bacterium (GO:0016045) | 5.24801086 |
| 9 | response to peptidoglycan (GO:0032494) | 5.21823763 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 5.08691158 |
| 11 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.96108604 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.89902720 |
| 13 | response to interleukin-15 (GO:0070672) | 4.88661028 |
| 14 | detection of external biotic stimulus (GO:0098581) | 4.70358274 |
| 15 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.67011841 |
| 16 | leukocyte aggregation (GO:0070486) | 4.65295366 |
| 17 | cellular response to interleukin-15 (GO:0071350) | 4.55448820 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 4.55360924 |
| 19 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.54586660 |
| 20 | positive regulation of antigen processing and presentation (GO:0002579) | 4.49336023 |
| 21 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.48492854 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.42075831 |
| 23 | positive regulation of interleukin-12 production (GO:0032735) | 4.37983711 |
| 24 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.36762134 |
| 25 | negative regulation of interleukin-12 production (GO:0032695) | 4.36282155 |
| 26 | T-helper 1 type immune response (GO:0042088) | 4.35279157 |
| 27 | myeloid dendritic cell differentiation (GO:0043011) | 4.33360826 |
| 28 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 4.32459148 |
| 29 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 4.28877760 |
| 30 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.28297914 |
| 31 | respiratory burst (GO:0045730) | 4.27723022 |
| 32 | cellular extravasation (GO:0045123) | 4.17609982 |
| 33 | dendritic cell chemotaxis (GO:0002407) | 4.09250188 |
| 34 | detection of biotic stimulus (GO:0009595) | 4.08225762 |
| 35 | positive regulation of type 2 immune response (GO:0002830) | 4.07833707 |
| 36 | negative regulation of leukocyte mediated immunity (GO:0002704) | 4.07198930 |
| 37 | regulation of hypersensitivity (GO:0002883) | 4.04995482 |
| 38 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.98855142 |
| 39 | response to muramyl dipeptide (GO:0032495) | 3.98632714 |
| 40 | growth hormone receptor signaling pathway (GO:0060396) | 3.95632489 |
| 41 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.94720184 |
| 42 | natural killer cell mediated immunity (GO:0002228) | 3.94720184 |
| 43 | myeloid dendritic cell activation (GO:0001773) | 3.94150798 |
| 44 | regulation of gamma-delta T cell activation (GO:0046643) | 3.92979940 |
| 45 | regulation of antigen processing and presentation (GO:0002577) | 3.92911527 |
| 46 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.92801452 |
| 47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.89611749 |
| 48 | regulation of RIG-I signaling pathway (GO:0039535) | 3.88744099 |
| 49 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.87762763 |
| 50 | response to host (GO:0075136) | 3.86444960 |
| 51 | response to host defenses (GO:0052200) | 3.86444960 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.86444960 |
| 53 | microglial cell activation (GO:0001774) | 3.85713459 |
| 54 | regulation of memory T cell differentiation (GO:0043380) | 3.82403168 |
| 55 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.81104688 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 3.80078443 |
| 57 | superoxide anion generation (GO:0042554) | 3.78163413 |
| 58 | myeloid cell activation involved in immune response (GO:0002275) | 3.76833467 |
| 59 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.74169901 |
| 60 | negative regulation of phagocytosis (GO:0050765) | 3.73023957 |
| 61 | dendritic cell migration (GO:0036336) | 3.71274337 |
| 62 | macrophage activation (GO:0042116) | 3.69303230 |
| 63 | regulation of interleukin-12 production (GO:0032655) | 3.65511716 |
| 64 | regulation of T-helper cell differentiation (GO:0045622) | 3.65154981 |
| 65 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.60978369 |
| 66 | leukocyte mediated cytotoxicity (GO:0001909) | 3.60436842 |
| 67 | neutrophil mediated immunity (GO:0002446) | 3.59689275 |
| 68 | negative regulation of T cell mediated immunity (GO:0002710) | 3.59169022 |
| 69 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.57125848 |
| 70 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.56017300 |
| 71 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.54528583 |
| 72 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.54510810 |
| 73 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.53288499 |
| 74 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.52666141 |
| 75 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.52666141 |
| 76 | T-helper cell differentiation (GO:0042093) | 3.50589780 |
| 77 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.50589780 |
| 78 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.50439842 |
| 79 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.50197255 |
| 80 | germinal center formation (GO:0002467) | 3.49339385 |
| 81 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.48468103 |
| 82 | positive regulation of humoral immune response (GO:0002922) | 3.48361584 |
| 83 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.48334346 |
| 84 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.48334346 |
| 85 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.48213491 |
| 86 | immunoglobulin mediated immune response (GO:0016064) | 3.48101891 |
| 87 | leukocyte degranulation (GO:0043299) | 3.45423697 |
| 88 | type I interferon signaling pathway (GO:0060337) | 3.45164608 |
| 89 | cellular response to type I interferon (GO:0071357) | 3.45164608 |
| 90 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.44442832 |
| 91 | negative regulation of cell killing (GO:0031342) | 3.44293945 |
| 92 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.44293945 |
| 93 | regulation of T cell tolerance induction (GO:0002664) | 3.44081556 |
| 94 | positive regulation of interleukin-17 production (GO:0032740) | 3.43451730 |
| 95 | myeloid leukocyte mediated immunity (GO:0002444) | 3.40723302 |
| 96 | dendritic cell differentiation (GO:0097028) | 3.40122858 |
| 97 | response to type I interferon (GO:0034340) | 3.38806969 |
| 98 | T cell activation involved in immune response (GO:0002286) | 3.37766840 |
| 99 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.36913127 |
| 100 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.36218857 |
| 101 | regulation of leukocyte degranulation (GO:0043300) | 3.36095795 |
| 102 | response to fungus (GO:0009620) | 3.36015630 |
| 103 | positive regulation of interferon-alpha production (GO:0032727) | 3.35998111 |
| 104 | negative thymic T cell selection (GO:0045060) | 3.35610246 |
| 105 | cellular response to growth hormone stimulus (GO:0071378) | 3.34605350 |
| 106 | positive regulation of T cell cytokine production (GO:0002726) | 3.33662849 |
| 107 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.29671671 |
| 108 | B cell receptor signaling pathway (GO:0050853) | 3.28839173 |
| 109 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.28680225 |
| 110 | regulation of tolerance induction (GO:0002643) | 3.27712312 |
| 111 | regulation of immunoglobulin secretion (GO:0051023) | 3.26777699 |
| 112 | response to host immune response (GO:0052572) | 3.26484129 |
| 113 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26484129 |
| 114 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.26472986 |
| 115 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.26447292 |
| 116 | regulation of mast cell activation (GO:0033003) | 3.24928605 |
| 117 | natural killer cell activation involved in immune response (GO:0002323) | 3.24109833 |
| 118 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.23938632 |
| 119 | regulation of interferon-alpha production (GO:0032647) | 3.21662329 |
| 120 | negative regulation of type 2 immune response (GO:0002829) | 3.20966535 |
| 121 | regulation of T-helper 1 type immune response (GO:0002825) | 3.20790471 |
| 122 | positive regulation of interleukin-2 production (GO:0032743) | 3.20575037 |
| 123 | eosinophil migration (GO:0072677) | 3.20481035 |
| 124 | negative regulation of interleukin-17 production (GO:0032700) | 3.19981335 |
| 125 | regulation of B cell differentiation (GO:0045577) | 3.19537680 |
| 126 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.19162439 |
| 127 | defense response to protozoan (GO:0042832) | 3.18173867 |
| 128 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.17614450 |
| 129 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.17282866 |
| 130 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.16340942 |
| 131 | positive regulation of mast cell activation (GO:0033005) | 3.14916185 |
| 132 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.14760768 |
| 133 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.14699687 |
| 134 | neutrophil chemotaxis (GO:0030593) | 3.13156992 |
| 135 | positive regulation of interleukin-10 production (GO:0032733) | 3.12482579 |
| 136 | negative regulation of interleukin-6 production (GO:0032715) | 3.12326296 |
| 137 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.11581308 |
| 138 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.11581308 |
| 139 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.10901837 |
| 140 | negative T cell selection (GO:0043383) | 3.08945197 |
| 141 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08560331 |
| 142 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08560331 |
| 143 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08560331 |
| 144 | modulation by symbiont of host immune response (GO:0052553) | 3.08560331 |
| 145 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08560331 |
| 146 | modulation by symbiont of host defense response (GO:0052031) | 3.08560331 |
| 147 | B cell mediated immunity (GO:0019724) | 3.08504552 |
| 148 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.08108497 |
| 149 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.07849106 |
| 150 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.07849106 |
| 151 | T cell differentiation involved in immune response (GO:0002292) | 3.07849106 |
| 152 | negative regulation of innate immune response (GO:0045824) | 3.06394873 |
| 153 | response to interferon-alpha (GO:0035455) | 3.04069934 |
| 154 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.02825159 |
| 155 | regulation of regulated secretory pathway (GO:1903305) | 3.02181833 |
| 156 | neutrophil migration (GO:1990266) | 2.98175806 |
| 157 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.93243659 |
| 158 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.92174774 |
| 159 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91889584 |
| 160 | tolerance induction (GO:0002507) | 2.91781055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.13988264 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.33630734 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.00775153 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.74808933 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.62476395 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.28309729 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.11607964 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.91099589 |
| 9 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.55085205 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.54454068 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.52805098 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.52768796 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.50861336 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.49244702 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18125763 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.17733165 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.12267875 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.94843773 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.82876658 |
| 20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.36502615 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.26435415 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 2.24475806 |
| 23 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05778690 |
| 24 | * MYB_26560356_Chip-Seq_TH2_Human | 2.02624660 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.01020443 |
| 26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.99880549 |
| 27 | * MAF_26560356_Chip-Seq_TH1_Human | 1.99179551 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93974426 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92917777 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84191843 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.77102868 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.74592061 |
| 33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.68431987 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.62974636 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.61793548 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59126701 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58449338 |
| 38 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.57213379 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.55543331 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55474290 |
| 41 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.55386810 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55357788 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.51601575 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46686012 |
| 45 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.44265412 |
| 46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44226001 |
| 47 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40532270 |
| 48 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38752806 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.37411074 |
| 50 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.35658633 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30132068 |
| 52 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.29160618 |
| 53 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28578132 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.27598139 |
| 55 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.27411760 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26212032 |
| 57 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26037594 |
| 58 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25439305 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25328097 |
| 60 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23889237 |
| 61 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.20900595 |
| 62 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20708081 |
| 63 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20401567 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19838011 |
| 65 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19003394 |
| 66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.17408622 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.15111514 |
| 68 | * MAF_26560356_Chip-Seq_TH2_Human | 1.12928246 |
| 69 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.12890190 |
| 70 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11854939 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09180275 |
| 72 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08673218 |
| 73 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06385986 |
| 74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06169026 |
| 75 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05392469 |
| 76 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05378800 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03023070 |
| 78 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02559369 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.97161979 |
| 80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96369321 |
| 81 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95767528 |
| 82 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95413286 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95042355 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.94418209 |
| 85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93641379 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.92665234 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91905274 |
| 88 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.91827382 |
| 89 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91633357 |
| 90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.89136644 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88112545 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.85780987 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82951665 |
| 94 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82870827 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82085898 |
| 96 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81418278 |
| 97 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79328115 |
| 98 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.78390583 |
| 99 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.74283488 |
| 100 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.74283488 |
| 101 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.72733838 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.70655066 |
| 103 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70167071 |
| 104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.68742737 |
| 105 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.65845786 |
| 106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.61206550 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.60344820 |
| 108 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.60003809 |
| 109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.59988651 |
| 110 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.59590758 |
| 111 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.58734727 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.58643249 |
| 113 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.58219826 |
| 114 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.58219826 |
| 115 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.58219826 |
| 116 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.57814028 |
| 117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.56278290 |
| 118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.54959756 |
| 119 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.54407919 |
| 120 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.54333371 |
| 121 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.52745408 |
| 122 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.51279803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.68672990 |
| 2 | MP0003436_decreased_susceptibility_to | 4.10744799 |
| 3 | MP0009785_altered_susceptibility_to | 4.07945178 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.62750380 |
| 5 | MP0000685_abnormal_immune_system | 3.51583450 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 3.48991761 |
| 7 | MP0001348_abnormal_lacrimal_gland | 3.19843100 |
| 8 | MP0003303_peritoneal_inflammation | 3.16968481 |
| 9 | MP0005671_abnormal_response_to | 3.15971344 |
| 10 | MP0002163_abnormal_gland_morphology | 3.13558916 |
| 11 | MP0004510_myositis | 3.04543197 |
| 12 | MP0005000_abnormal_immune_tolerance | 3.01734561 |
| 13 | MP0001790_abnormal_immune_system | 2.93368512 |
| 14 | MP0005387_immune_system_phenotype | 2.93368512 |
| 15 | MP0002419_abnormal_innate_immunity | 2.88524867 |
| 16 | MP0005025_abnormal_response_to | 2.81794166 |
| 17 | MP0001800_abnormal_humoral_immune | 2.57514666 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.54123245 |
| 19 | MP0002723_abnormal_immune_serum | 2.46136868 |
| 20 | MP0009278_abnormal_bone_marrow | 2.34579511 |
| 21 | MP0001819_abnormal_immune_cell | 2.34192747 |
| 22 | MP0001853_heart_inflammation | 2.30016397 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.28849024 |
| 24 | MP0002132_abnormal_respiratory_system | 2.25917393 |
| 25 | MP0005310_abnormal_salivary_gland | 2.25133718 |
| 26 | MP0001346_abnormal_lacrimal_gland | 2.06780429 |
| 27 | MP0003724_increased_susceptibility_to | 2.03014749 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 2.02534437 |
| 29 | MP0002254_reproductive_system_inflammat | 2.01414110 |
| 30 | MP0002006_tumorigenesis | 2.00879002 |
| 31 | MP0002166_altered_tumor_susceptibility | 1.96832758 |
| 32 | MP0002405_respiratory_system_inflammati | 1.92194751 |
| 33 | MP0009764_decreased_sensitivity_to | 1.82363042 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.82343312 |
| 35 | MP0000716_abnormal_immune_system | 1.77604998 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.76055737 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.76055737 |
| 38 | MP0006082_CNS_inflammation | 1.72487355 |
| 39 | MP0000465_gastrointestinal_hemorrhage | 1.72235986 |
| 40 | MP0002398_abnormal_bone_marrow | 1.71945202 |
| 41 | MP0003866_abnormal_defecation | 1.70944804 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.70200240 |
| 43 | MP0003448_altered_tumor_morphology | 1.70135564 |
| 44 | MP0000858_altered_metastatic_potential | 1.61477084 |
| 45 | MP0000569_abnormal_digit_pigmentation | 1.60332454 |
| 46 | MP0005451_abnormal_body_composition | 1.56563946 |
| 47 | MP0004381_abnormal_hair_follicle | 1.54130757 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.52855638 |
| 49 | MP0005379_endocrine/exocrine_gland_phen | 1.47070082 |
| 50 | MP0004947_skin_inflammation | 1.46858736 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.39856098 |
| 52 | MP0002429_abnormal_blood_cell | 1.38077460 |
| 53 | MP0005167_abnormal_blood-brain_barrier | 1.37784197 |
| 54 | MP0008469_abnormal_protein_level | 1.32578556 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.23785834 |
| 56 | MP0000343_altered_response_to | 1.23613121 |
| 57 | MP0008260_abnormal_autophagy | 1.21155628 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.21086731 |
| 59 | MP0002722_abnormal_immune_system | 1.20003693 |
| 60 | MP0004808_abnormal_hematopoietic_stem | 1.19471362 |
| 61 | MP0000689_abnormal_spleen_morphology | 1.17847270 |
| 62 | MP0009333_abnormal_splenocyte_physiolog | 1.14894499 |
| 63 | MP0003075_altered_response_to | 1.10914241 |
| 64 | MP0002009_preneoplasia | 1.09165838 |
| 65 | MP0002735_abnormal_chemical_nociception | 1.06444729 |
| 66 | MP0003763_abnormal_thymus_physiology | 1.05016057 |
| 67 | MP0005174_abnormal_tail_pigmentation | 1.04643352 |
| 68 | MP0003878_abnormal_ear_physiology | 1.03702375 |
| 69 | MP0005377_hearing/vestibular/ear_phenot | 1.03702375 |
| 70 | MP0001873_stomach_inflammation | 1.02907359 |
| 71 | MP0002396_abnormal_hematopoietic_system | 1.00739672 |
| 72 | MP0002933_joint_inflammation | 1.00569243 |
| 73 | MP0008057_abnormal_DNA_replication | 1.00261921 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.97296574 |
| 75 | MP0003690_abnormal_glial_cell | 0.97293819 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 0.91911980 |
| 77 | MP0004883_abnormal_blood_vessel | 0.90699666 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 0.88207866 |
| 79 | MP0004858_abnormal_nervous_system | 0.87148143 |
| 80 | MP0003045_fibrosis | 0.85129955 |
| 81 | MP0003300_gastrointestinal_ulcer | 0.85018291 |
| 82 | MP0003091_abnormal_cell_migration | 0.84879893 |
| 83 | MP0008004_abnormal_stomach_pH | 0.83064158 |
| 84 | MP0001663_abnormal_digestive_system | 0.82902082 |
| 85 | MP0000703_abnormal_thymus_morphology | 0.79488589 |
| 86 | MP0000015_abnormal_ear_pigmentation | 0.78561586 |
| 87 | MP0005390_skeleton_phenotype | 0.78391706 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.76669355 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.76273811 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.76148702 |
| 91 | MP0002877_abnormal_melanocyte_morpholog | 0.74067863 |
| 92 | MP0010307_abnormal_tumor_latency | 0.73296923 |
| 93 | MP0005058_abnormal_lysosome_morphology | 0.72002054 |
| 94 | MP0003828_pulmonary_edema | 0.69424173 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.69213933 |
| 96 | MP0005164_abnormal_response_to | 0.68550284 |
| 97 | MP0009763_increased_sensitivity_to | 0.66505066 |
| 98 | MP0003172_abnormal_lysosome_physiology | 0.66387468 |
| 99 | MP0001881_abnormal_mammary_gland | 0.66342726 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.66279693 |
| 101 | MP0005248_abnormal_Harderian_gland | 0.65611939 |
| 102 | MP0003795_abnormal_bone_structure | 0.64302778 |
| 103 | MP0000249_abnormal_blood_vessel | 0.63393799 |
| 104 | MP0008874_decreased_physiological_sensi | 0.62167805 |
| 105 | MP0005319_abnormal_enzyme/_coenzyme | 0.61499409 |
| 106 | MP0003186_abnormal_redox_activity | 0.61067917 |
| 107 | MP0001851_eye_inflammation | 0.60582639 |
| 108 | MP0003221_abnormal_cardiomyocyte_apopto | 0.59862899 |
| 109 | MP0005166_decreased_susceptibility_to | 0.59539987 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.59425290 |
| 111 | MP0005083_abnormal_biliary_tract | 0.59086459 |
| 112 | MP0002019_abnormal_tumor_incidence | 0.57585331 |
| 113 | MP0002736_abnormal_nociception_after | 0.56573070 |
| 114 | MP0004130_abnormal_muscle_cell | 0.56049076 |
| 115 | MP0002133_abnormal_respiratory_system | 0.54464543 |
| 116 | MP0005388_respiratory_system_phenotype | 0.54464543 |
| 117 | MP0000627_abnormal_mammary_gland | 0.53756867 |
| 118 | MP0000604_amyloidosis | 0.52705383 |
| 119 | MP0001968_abnormal_touch/_nociception | 0.51967659 |
| 120 | MP0002653_abnormal_ependyma_morphology | 0.51446906 |
| 121 | MP0000490_abnormal_crypts_of | 0.50916072 |
| 122 | MP0000371_diluted_coat_color | 0.50420593 |
| 123 | MP0003191_abnormal_cellular_cholesterol | 0.50315482 |
| 124 | MP0002928_abnormal_bile_duct | 0.49643184 |
| 125 | MP0000516_abnormal_urinary_system | 0.47728024 |
| 126 | MP0001958_emphysema | 0.46967711 |
| 127 | MP0002693_abnormal_pancreas_physiology | 0.46939742 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.44566621 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.79767729 |
| 2 | Recurrent abscess formation (HP:0002722) | 7.36205570 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.82444133 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.27291128 |
| 5 | Optic neuritis (HP:0100653) | 5.46459142 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.46459142 |
| 7 | Abnormality of macrophages (HP:0004311) | 5.45048383 |
| 8 | Orchitis (HP:0100796) | 5.24470787 |
| 9 | Mediastinal lymphadenopathy (HP:0100721) | 5.24055084 |
| 10 | Myositis (HP:0100614) | 5.12920599 |
| 11 | Increased IgM level (HP:0003496) | 5.05372840 |
| 12 | Hypochromic microcytic anemia (HP:0004840) | 5.03640180 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.91481390 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 4.62786027 |
| 15 | Obstructive lung disease (HP:0006536) | 4.62786027 |
| 16 | Gastrointestinal infarctions (HP:0005244) | 4.53252138 |
| 17 | Gingivitis (HP:0000230) | 4.44663953 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 4.33847587 |
| 19 | Recurrent skin infections (HP:0001581) | 4.21268215 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.11772872 |
| 21 | Vasculitis (HP:0002633) | 4.05527106 |
| 22 | Stomatitis (HP:0010280) | 3.95440186 |
| 23 | Chronic otitis media (HP:0000389) | 3.83620923 |
| 24 | Episodic fever (HP:0001954) | 3.46412989 |
| 25 | Recurrent viral infections (HP:0004429) | 3.46030614 |
| 26 | Keratoconjunctivitis sicca (HP:0001097) | 3.45399498 |
| 27 | Cellulitis (HP:0100658) | 3.43463399 |
| 28 | Prolonged bleeding time (HP:0003010) | 3.39207364 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.37350447 |
| 30 | Meningitis (HP:0001287) | 3.36720239 |
| 31 | Urticaria (HP:0001025) | 3.35328608 |
| 32 | Leukocytosis (HP:0001974) | 3.25558435 |
| 33 | Keratoconjunctivitis (HP:0001096) | 3.18603782 |
| 34 | Recurrent cutaneous fungal infections (HP:0011370) | 3.14627464 |
| 35 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.14627464 |
| 36 | Arterial thrombosis (HP:0004420) | 3.12340957 |
| 37 | Eosinophilia (HP:0001880) | 3.05294368 |
| 38 | Pulmonary infiltrates (HP:0002113) | 3.04678734 |
| 39 | Hypergammaglobulinemia (HP:0010702) | 3.00370197 |
| 40 | Hemoptysis (HP:0002105) | 2.92630510 |
| 41 | Abnormality of T cell number (HP:0011839) | 2.87496038 |
| 42 | Microcytic anemia (HP:0001935) | 2.86688458 |
| 43 | Recurrent pneumonia (HP:0006532) | 2.80631820 |
| 44 | Periodontitis (HP:0000704) | 2.74345185 |
| 45 | Gastrointestinal inflammation (HP:0004386) | 2.70905078 |
| 46 | Granulocytopenia (HP:0001913) | 2.65925839 |
| 47 | Hypochromic anemia (HP:0001931) | 2.64629332 |
| 48 | Increased IgE level (HP:0003212) | 2.63502015 |
| 49 | Tetraparesis (HP:0002273) | 2.62459689 |
| 50 | Epistaxis (HP:0000421) | 2.60725573 |
| 51 | Nasal polyposis (HP:0100582) | 2.59426366 |
| 52 | Basal ganglia calcification (HP:0002135) | 2.58191634 |
| 53 | Thyroiditis (HP:0100646) | 2.57835245 |
| 54 | Panhypogammaglobulinemia (HP:0003139) | 2.56724675 |
| 55 | Peritonitis (HP:0002586) | 2.56350369 |
| 56 | Abnormality of eosinophils (HP:0001879) | 2.53965685 |
| 57 | Osteomyelitis (HP:0002754) | 2.51012775 |
| 58 | Encephalitis (HP:0002383) | 2.48766516 |
| 59 | Gingival bleeding (HP:0000225) | 2.48412332 |
| 60 | Spontaneous hematomas (HP:0007420) | 2.46525893 |
| 61 | Abnormality of the peritoneum (HP:0002585) | 2.43897569 |
| 62 | Porencephaly (HP:0002132) | 2.42851745 |
| 63 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.38498229 |
| 64 | Recurrent lower respiratory tract infections (HP:0002783) | 2.37077573 |
| 65 | Chest pain (HP:0100749) | 2.32603825 |
| 66 | Premature loss of primary teeth (HP:0006323) | 2.31491720 |
| 67 | Interstitial pulmonary disease (HP:0006530) | 2.31207844 |
| 68 | Hematochezia (HP:0002573) | 2.30455805 |
| 69 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.24295538 |
| 70 | Sepsis (HP:0100806) | 2.24253983 |
| 71 | Metaphyseal cupping (HP:0003021) | 2.24154983 |
| 72 | Abnormality of the nasal mucosa (HP:0000433) | 2.22908217 |
| 73 | Toxemia of pregnancy (HP:0100603) | 2.22394988 |
| 74 | Anorexia (HP:0002039) | 2.21514392 |
| 75 | Pustule (HP:0200039) | 2.18354630 |
| 76 | Autoimmune hemolytic anemia (HP:0001890) | 2.18285753 |
| 77 | Glomerulopathy (HP:0100820) | 2.15895436 |
| 78 | Chronic sinusitis (HP:0011109) | 2.13473340 |
| 79 | Skin ulcer (HP:0200042) | 2.13098916 |
| 80 | Gangrene (HP:0100758) | 2.12977446 |
| 81 | Joint swelling (HP:0001386) | 2.12856388 |
| 82 | Systemic lupus erythematosus (HP:0002725) | 2.12639131 |
| 83 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12584528 |
| 84 | Acne (HP:0001061) | 2.11952988 |
| 85 | Lymphopenia (HP:0001888) | 2.11882771 |
| 86 | Amaurosis fugax (HP:0100576) | 2.09504817 |
| 87 | Fatigue (HP:0012378) | 2.08973887 |
| 88 | Abnormality of T cells (HP:0002843) | 2.08641903 |
| 89 | Keratitis (HP:0000491) | 2.07984781 |
| 90 | Abnormal platelet volume (HP:0011876) | 2.07712527 |
| 91 | Difficulty running (HP:0009046) | 2.06961969 |
| 92 | Agammaglobulinemia (HP:0004432) | 2.06876176 |
| 93 | T lymphocytopenia (HP:0005403) | 2.06031317 |
| 94 | IgM deficiency (HP:0002850) | 2.03017439 |
| 95 | Recurrent bronchitis (HP:0002837) | 2.02881347 |
| 96 | Pulmonary embolism (HP:0002204) | 2.02048526 |
| 97 | Myocardial infarction (HP:0001658) | 2.01997940 |
| 98 | Purpura (HP:0000979) | 2.01968472 |
| 99 | Acute hepatic failure (HP:0006554) | 2.00750415 |
| 100 | Slow saccadic eye movements (HP:0000514) | 1.99387115 |
| 101 | Colitis (HP:0002583) | 1.98923251 |
| 102 | Abnormality of T cell physiology (HP:0011840) | 1.98318996 |
| 103 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.96299679 |
| 104 | Vertigo (HP:0002321) | 1.94520301 |
| 105 | Polycythemia (HP:0001901) | 1.91250772 |
| 106 | Hypermelanotic macule (HP:0001034) | 1.90953502 |
| 107 | Vacuolated lymphocytes (HP:0001922) | 1.88654534 |
| 108 | Abnormality of the fingertips (HP:0001211) | 1.88041618 |
| 109 | Abnormality of the pleura (HP:0002103) | 1.87035269 |
| 110 | Hepatosplenomegaly (HP:0001433) | 1.86365266 |
| 111 | Petechiae (HP:0000967) | 1.86271483 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 1.86202151 |
| 113 | Loss of speech (HP:0002371) | 1.85654290 |
| 114 | Abnormality of the endocardium (HP:0004306) | 1.85397099 |
| 115 | Increased serum ferritin (HP:0003281) | 1.84665074 |
| 116 | Subacute progressive viral hepatitis (HP:0006572) | 1.84469684 |
| 117 | Arthralgia (HP:0002829) | 1.84362646 |
| 118 | Viral hepatitis (HP:0006562) | 1.81650970 |
| 119 | Thrombocytosis (HP:0001894) | 1.81491103 |
| 120 | Cleft eyelid (HP:0000625) | 1.80191400 |
| 121 | Abnormal hemoglobin (HP:0011902) | 1.79887538 |
| 122 | Neutropenia (HP:0001875) | 1.79826777 |
| 123 | Vertebral compression fractures (HP:0002953) | 1.78853813 |
| 124 | Skin rash (HP:0000988) | 1.78790714 |
| 125 | Anhidrosis (HP:0000970) | 1.77813025 |
| 126 | Cerebral ischemia (HP:0002637) | 1.76828466 |
| 127 | Prostate neoplasm (HP:0100787) | 1.76131530 |
| 128 | Abnormality of proline metabolism (HP:0010907) | 1.75425815 |
| 129 | Hydroxyprolinuria (HP:0003080) | 1.75425815 |
| 130 | Inflammation of the large intestine (HP:0002037) | 1.74596863 |
| 131 | Abnormality of the pericardium (HP:0001697) | 1.73685955 |
| 132 | Amyloidosis (HP:0011034) | 1.73500631 |
| 133 | Osteolytic defects of the hand bones (HP:0009699) | 1.73178577 |
| 134 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.73178577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.62449828 |
| 2 | IRAK4 | 4.55038468 |
| 3 | RIPK4 | 3.40046013 |
| 4 | TYK2 | 3.39358326 |
| 5 | BLK | 3.25909595 |
| 6 | IKBKB | 3.21737397 |
| 7 | TBK1 | 3.07787536 |
| 8 | TNK2 | 2.84551870 |
| 9 | JAK3 | 2.82489301 |
| 10 | EPHB1 | 2.77737452 |
| 11 | MAP3K13 | 2.70423083 |
| 12 | IKBKE | 2.58164840 |
| 13 | IRAK3 | 2.42033263 |
| 14 | CHUK | 2.30092476 |
| 15 | TAOK1 | 2.20124212 |
| 16 | MAP3K3 | 1.98868458 |
| 17 | JAK1 | 1.96498383 |
| 18 | PRPF4B | 1.79136309 |
| 19 | SIK3 | 1.68727521 |
| 20 | PBK | 1.66119466 |
| 21 | EPHA3 | 1.65110790 |
| 22 | BTK | 1.57922763 |
| 23 | MAP4K1 | 1.55782685 |
| 24 | FGR | 1.55514559 |
| 25 | CSK | 1.55077746 |
| 26 | TXK | 1.49679207 |
| 27 | PIM2 | 1.43500452 |
| 28 | BCR | 1.34144094 |
| 29 | TEC | 1.33517255 |
| 30 | PIM1 | 1.32171960 |
| 31 | STK4 | 1.27392758 |
| 32 | HCK | 1.26562103 |
| 33 | EIF2AK2 | 1.24400463 |
| 34 | SYK | 1.22888794 |
| 35 | PRKD2 | 1.21950362 |
| 36 | TRPM7 | 1.19126857 |
| 37 | FGFR3 | 1.16109734 |
| 38 | MARK2 | 1.15360328 |
| 39 | NEK9 | 1.13454634 |
| 40 | MST4 | 1.12598778 |
| 41 | MARK3 | 1.12214371 |
| 42 | SMG1 | 1.09920197 |
| 43 | TRIB3 | 1.07697318 |
| 44 | FES | 1.07082913 |
| 45 | IRAK1 | 1.06225149 |
| 46 | JAK2 | 1.02260961 |
| 47 | MAP3K12 | 1.01253345 |
| 48 | FGFR4 | 1.00309328 |
| 49 | KIT | 0.99125068 |
| 50 | GRK6 | 0.99034801 |
| 51 | CDK19 | 0.99027639 |
| 52 | MAP3K9 | 0.98792082 |
| 53 | BMPR2 | 0.98762898 |
| 54 | LCK | 0.94147162 |
| 55 | ZAP70 | 0.90373745 |
| 56 | MAP3K6 | 0.89443015 |
| 57 | FRK | 0.87223257 |
| 58 | TAOK2 | 0.87035977 |
| 59 | PDK1 | 0.85049857 |
| 60 | YES1 | 0.84127394 |
| 61 | CSF1R | 0.84111722 |
| 62 | PTK6 | 0.83391458 |
| 63 | STK10 | 0.83039680 |
| 64 | LYN | 0.79011935 |
| 65 | ALK | 0.78552717 |
| 66 | MAP3K7 | 0.78503916 |
| 67 | MAP2K4 | 0.78336195 |
| 68 | RPS6KA4 | 0.77429113 |
| 69 | CLK1 | 0.77302082 |
| 70 | PDPK1 | 0.77166741 |
| 71 | NLK | 0.76638966 |
| 72 | MAP2K3 | 0.76111907 |
| 73 | PRKCD | 0.73664085 |
| 74 | PKN1 | 0.72430610 |
| 75 | FYN | 0.72284961 |
| 76 | STK38 | 0.71675631 |
| 77 | MAPKAPK2 | 0.71394675 |
| 78 | BMX | 0.65559237 |
| 79 | SIK2 | 0.65228079 |
| 80 | DYRK1B | 0.65207295 |
| 81 | ITK | 0.64895879 |
| 82 | SIK1 | 0.64476512 |
| 83 | PRKG2 | 0.64178320 |
| 84 | KSR2 | 0.63744284 |
| 85 | ERBB3 | 0.63010452 |
| 86 | MAP3K2 | 0.62676274 |
| 87 | TESK1 | 0.62219079 |
| 88 | CDK12 | 0.61433322 |
| 89 | TESK2 | 0.59370832 |
| 90 | ARAF | 0.58697512 |
| 91 | NUAK1 | 0.57813525 |
| 92 | MAP2K6 | 0.57529582 |
| 93 | MAPK12 | 0.57213088 |
| 94 | MAP3K5 | 0.54990385 |
| 95 | CDC42BPA | 0.54344651 |
| 96 | MAP3K11 | 0.52995412 |
| 97 | RPS6KA1 | 0.52853016 |
| 98 | PRKAA2 | 0.52747149 |
| 99 | KDR | 0.52413854 |
| 100 | TGFBR2 | 0.51951624 |
| 101 | RAF1 | 0.51766906 |
| 102 | DAPK2 | 0.51121308 |
| 103 | HIPK2 | 0.50419247 |
| 104 | LRRK2 | 0.49858096 |
| 105 | IRAK2 | 0.49776524 |
| 106 | RET | 0.49694033 |
| 107 | MATK | 0.48205326 |
| 108 | SGK3 | 0.45900431 |
| 109 | KSR1 | 0.45821468 |
| 110 | RPS6KL1 | 0.44783679 |
| 111 | RPS6KC1 | 0.44783679 |
| 112 | MAPK7 | 0.44287569 |
| 113 | ABL1 | 0.42792380 |
| 114 | PRKCQ | 0.42733463 |
| 115 | PAK4 | 0.42315362 |
| 116 | ABL2 | 0.36364294 |
| 117 | STK24 | 0.35003463 |
| 118 | PTK2B | 0.34565570 |
| 119 | PIK3CG | 0.34250476 |
| 120 | EGFR | 0.34201265 |
| 121 | PRKCH | 0.34171152 |
| 122 | MAP3K1 | 0.34029730 |
| 123 | ERN1 | 0.33976253 |
| 124 | RPS6KA5 | 0.31692198 |
| 125 | AKT1 | 0.30947875 |
| 126 | BMPR1B | 0.29669662 |
| 127 | RPS6KA6 | 0.29283360 |
| 128 | PRKCZ | 0.28876462 |
| 129 | CAMKK1 | 0.27329266 |
| 130 | PTK2 | 0.26231412 |
| 131 | MAP2K2 | 0.25456417 |
| 132 | MAP3K8 | 0.24148743 |
| 133 | RPS6KA2 | 0.21845599 |
| 134 | MOS | 0.21327097 |
| 135 | TAOK3 | 0.21265859 |
| 136 | STK11 | 0.20744039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.05562181 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.53273753 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.28553327 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.76558770 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.71087267 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.60466033 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.60053897 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.45113635 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.40543075 |
| 10 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.26765156 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.24417293 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.19797887 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10817604 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.10637713 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.10304278 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.91627751 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.88465779 |
| 18 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.86765115 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.78765116 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.77948329 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.73948325 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.70061348 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68421101 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.67821665 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.66336976 |
| 26 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.59906207 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.57744148 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.55735583 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.55338547 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.54492414 |
| 31 | Apoptosis_Homo sapiens_hsa04210 | 1.49899019 |
| 32 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47548505 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.38005708 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37319272 |
| 35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31302531 |
| 36 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.30920038 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.29721275 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28723138 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26819438 |
| 40 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22267655 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.20496103 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.14142788 |
| 43 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08793664 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.06999438 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.00988616 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.00658266 |
| 47 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96565419 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 0.96020879 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.94722481 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86723564 |
| 51 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86230690 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85049695 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.84225835 |
| 54 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83370511 |
| 55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82750633 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78694166 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78484623 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.76363988 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74683072 |
| 60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73785276 |
| 61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73495663 |
| 62 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.73420626 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66913206 |
| 64 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65692211 |
| 65 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65545772 |
| 66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65396055 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.62767914 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61654463 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59827187 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58974461 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57246796 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56022757 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55842499 |
| 74 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55829881 |
| 75 | Proteasome_Homo sapiens_hsa03050 | 0.55111777 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.50132791 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47964614 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47605736 |
| 79 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45697653 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43400809 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42746440 |
| 82 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42459113 |
| 83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.41875286 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41330554 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40297023 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39275434 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38959178 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38595646 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37539659 |
| 90 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36732869 |
| 91 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36443864 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.34638965 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.33874590 |
| 94 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32710590 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.31922397 |
| 96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.30567618 |
| 97 | Adherens junction_Homo sapiens_hsa04520 | 0.28913823 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.28249247 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27172184 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25867124 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25272881 |
| 102 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.22974602 |
| 103 | Endometrial cancer_Homo sapiens_hsa05213 | 0.21454220 |
| 104 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21173048 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.19259451 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.19200184 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.18596046 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.16230177 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.14741960 |
| 110 | Colorectal cancer_Homo sapiens_hsa05210 | 0.14457170 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.13768786 |
| 112 | Bladder cancer_Homo sapiens_hsa05219 | 0.13626813 |
| 113 | Melanoma_Homo sapiens_hsa05218 | 0.13476271 |
| 114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13404268 |

